CLINICAL_TRIALS
withdrawal
· 2012-04-30
Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus [Phase 2]
Summary
A Phase 2 trial of R935788 for systemic lupus erythematosus has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigel Pharmaceuticals | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: WITHDRAWN